ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rosiglitazone Maleate And Metformin Hydrochloride, and when can generic versions of Rosiglitazone Maleate And Metformin Hydrochloride launch?
Rosiglitazone Maleate And Metformin Hydrochloride is a drug marketed by Teva and is included in one NDA.
The generic ingredient in ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE is metformin hydrochloride; rosiglitazone maleate. There are forty-nine drug master file entries for this compound. Additional details are available on the metformin hydrochloride; rosiglitazone maleate profile page.
Summary for ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Clinical Trials: | 5 |
Patent Applications: | 14 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GlaxoSmithKline | Phase 1 |
Daiichi Sankyo, Inc. | Phase 3 |
Daiichi Sankyo Inc. | Phase 3 |
See all ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
US Patents and Regulatory Information for ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; rosiglitazone maleate | TABLET;ORAL | 077337-004 | May 7, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva | ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; rosiglitazone maleate | TABLET;ORAL | 077337-005 | May 19, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva | ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; rosiglitazone maleate | TABLET;ORAL | 077337-003 | May 7, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |